# Regeneron Pharmaceuticals, Inc. (REGN) — Q4-2009 Earnings Results

**Report date:** 2010-02-18 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/REGN/earnings/Q4-2009

## Post-Earnings Brief

### Headline

Regeneron Pharmaceuticals Misses on EPS — Stock Down 12.48%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.46 | N/A | -35.69% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Overall, management acknowledged the difficulties faced during the quarter. They did not provide any forward guidance, indicating uncertainty about future performance.

**Key quotes:**

> Management expressed concerns over recent performance.

> They highlighted challenges in the current market environment.

> No specific guidance was provided for the upcoming quarters.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Regeneron's earnings report indicates a challenging quarter, particularly with a significant EPS miss. The stock reacted negatively, dropping 12.48%, likely due to investor concerns over the company's performance and lack of guidance. The absence of revenue figures further adds to the uncertainty surrounding the company's outlook.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/REGN/earnings/Q4-2009_